Dr Sue Pedersen publiczne
[search 0]
Więcej
Download the App!
show episodes
 
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine. Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixe ...
  continue reading
 
Loading …
show series
 
We are now very well acquainted with the efficacy of GLP1 receptor agonists (GLP1RAs) in weight management, like semaglutide (Wegovy/Ozempic) and liraglutide (Saxenda), and the dual GLP1/GIP agonist tirzepatide (Zepbound/Mounjaro). What is GLP2 (yes two), and could GLP2 receptor agonism be an untapped frontier in weight management medication? Learn…
  continue reading
 
Why is type 2 diabetes on the rise in younger people, why does it matter, and what can we do about it? Listen on to find out! Learn more: https://drsue.ca/2024/09/sounding-the-alarm-the-rising-tide-of-younger-onset-type-2-diabetes/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audi…
  continue reading
 
Could finerenone (kerendia) be a much-needed addition to the treatment approach in people with HFpEF? Find out here! Learn more: https://drsue.ca/2024/09/does-finerenone-kerendia-reduce-heart-failure-events-in-people-with-heart-failure-with-preserved-ejection-fraction-hfpef/ Any medical discussion on this podcast is intended to be of a general natu…
  continue reading
 
Some doctors and researchers are keen on the idea of inducing diabetes remission with lifestyle changes. A real-life implementation of the DiRECT lifestyle remission protocol was implemented in the UK. Was it successful, and what have we learned? Hint: People don't fail diets. Diets fail people. Read on! Learn more: https://drsue.ca/2024/09/diabete…
  continue reading
 
Could women have reproductive concerns related to elevated weight that is NOT PCOS? Introducing FOSH. Learn more: https://drsue.ca/2024/08/could-women-with-obesity-have-a-cause-of-infrequent-periods-or-fertility-concerns-that-is-not-pcos-introducing-fosh/ Any medical discussion on this podcast is intended to be of a general nature only, and is inte…
  continue reading
 
Semaglutide (Ozempic/Wegovy) reduces not only appetite, but also the reward experience of food and possibly even alcohol in our brains. Could it also make people less inclined to smoke? Learn more: https://drsue.ca/2024/08/could-ozempic-reduce-the-likelihood-of-nicotine-use/ Any medical discussion on this podcast is intended to be of a general natu…
  continue reading
 
Metreleptin is a human leptin analog, now approved and available in Canada for treatment of lipodystrophy. Learn more here! Learn more: https://drsue.ca/2024/08/leptin-analog-for-treatment-of-lipodystrophy-now-available-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audie…
  continue reading
 
Could your statin cholesterol medication cause diabetes? If you have diabetes, how much might your sugars rise with statin therapy? Learn more: https://drsue.ca/2024/08/could-your-statin-cholesterol-medication-cause-diabetes/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. …
  continue reading
 
One in three Canadian adults will get shingles at some point in their life. Shingles can be extremely painful, can occur in devastating locations, and can cause debilitating pain that can last months afterwards. Learn about the vaccine that can powerfully reduce the risk of getting shingles here! Learn more: https://drsue.ca/2024/07/should-you-get-…
  continue reading
 
Only a small fraction of people who may benefit from weight management medication are actually being prescribed treatment. What are the barriers to use of weight management medication, and how can we overcome them? Learn more: https://drsue.ca/2024/07/what-are-the-barriers-to-use-of-weight-management-medication-and-how-can-we-overcome-them/ Any med…
  continue reading
 
Once weekly basal (long acting) insulin is now available in Canada - the first country in the world to start using it. Find out more about insulin icodec (Awiqli) here! Learn more: https://drsue.ca/2024/07/once-weekly-insulin-now-available-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended …
  continue reading
 
A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop? Learn more: https://drsue.ca/2024/07/can-semaglutide-ozemp…
  continue reading
 
There are currently no medications to treat sleep apnea. Could tirzepatide (Zepbound/Mounjaro) treat sleep apnea along with providing weight loss? Learn more: https://drsue.ca/2024/06/can-tirzepatide-mounjaro-zepbound-treat-obstructive-sleep-apnea/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
Some people may lose too much muscle with weight loss medication. In preventing or rebuilding lost muscle, which is more important - dietary protein or physical activity? Learn more: https://drsue.ca/2024/06/preventing-or-rebuilding-muscle-loss-from-weight-loss-medication-is-dietary-protein-or-exercise-more-important/ Any medical discussion on this…
  continue reading
 
Elevated weight can be a cause or contributor to hypertension. Why is it so important to watch your blood pressure if you are on weight management medication? Learn more: https://drsue.ca/2024/06/watching-blood-pressure-on-weight-loss-medication-why-is-this-important/ Any medical discussion on this podcast is intended to be of a general nature only…
  continue reading
 
Obesity: are environmental chemicals at the center of the storm? Find out where these chemicals may reside.... even in our nonstick cookware. Eeew. Learn more: https://drsue.ca/2024/05/obesity-are-environmental-chemicals-at-the-center-of-the-storm/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
We know that GLP1 medications reduce protein in the urine in people with type 2 diabetes and kidney disease, but no study had ever been done to see whether GLP1 treatment could protect kidney function – until now. Learn more: https://drsue.ca/2024/05/semaglutide-first-glp1-medication-proven-to-provide-kidney-protection/ Any medical discussion on th…
  continue reading
 
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped? Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/…
  continue reading
 
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know? Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is n…
  continue reading
 
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
TRANSCRIPT Hi, Sophie here as usual. This is just a very short piece of audio to let you know that the Foodies podcast will be taking a bit of a holiday until the later half of this year. As keen listeners will know, I’m undertaking a PhD at the moment as well as working a part time job. The PhD is coming to the pointy end which means my time and b…
  continue reading
 
As many as 1 BILLION adults worldwide are estimated to have obstructive sleep apnea (OSA), and 70% of people with OSA have obesity. How much does sleep apnea improve with weight loss, and does it matter how the weight is lost (with lifestyle, weight management medication, or bariatric surgery)? Learn more: https://drsue.ca/2024/04/how-much-does-sle…
  continue reading
 
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us? Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/ Any medical discussion on this podca…
  continue reading
 
Older data have shown that obesity medications are prescribed far less frequently than medications for other chronic medical conditions. Much has changed in recent years in the weight management world. How has this impacted prescribing of weight management medication? Learn more: https://drsue.ca/2024/04/how-many-people-with-obesity-actually-receiv…
  continue reading
 
In this episode Kim Anastasiou, a Research Fellow at the Stretton Health Equity Institute of the University of Adelaide, unpacks the impact that ultra processed foods are having not just on our health but also our environment and what this means for the work we do and the world we live in. Kim is an advocate for the transformative changes needed to…
  continue reading
 
Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know? Learn more: https://drsue.ca/2024/04/mounjaro-ozemp…
  continue reading
 
Oprah Winfrey recently hosted a special called 'Shame, Blame, and the Weight Loss Revolution'. What will the Oprah Effect be on obesity medicine? Learn more: https://drsue.ca/2024/03/what-will-the-oprah-effect-be-on-obesity-medicine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian au…
  continue reading
 
Resmetirom is the first treatment ever approved for fatty liver disease. Could GLP1 based obesity/diabetes medications have similar benefits? Learn more: https://drsue.ca/2024/03/first-medication-ever-approved-to-treat-fatty-liver-disease-how-will-glp1-based-obesity-diabetes-medications-stack-up/ Any medical discussion on this podcast is intended t…
  continue reading
 
With the emergence of medications that are very powerful for weight loss, some people may lose too much weight. This can include excessive loss of muscle mass, a condition called sarcopenia. How should we look for and diagnose sarcopenia? Learn more: https://drsue.ca/2024/03/how-can-we-diagnose-sarcopenia-excessive-loss-of-muscle-in-people-successf…
  continue reading
 
The DiRECT 5 year trial of diabetes remission with lifestyle was just published. Does this study suggest that we should 'DiRECT' our patients towards lifestyle treatment alone? Learn more: https://drsue.ca/2024/03/diabetes-remission-should-we-direct-patients-towards-lifestyle-change-alone/ Any medical discussion on this podcast is intended to be of…
  continue reading
 
Guidelines currently recommend lifestyle change as a strategy to achieve diabetes remission. But is diabetes remission with lifestyle change alone a realistic long term goal? Learn more: https://drsue.ca/2024/02/is-diabetes-remission-with-lifestyle-change-a-realistic-long-term-goal/ Any medical discussion on this podcast is intended to be of a gene…
  continue reading
 
Dr. Fiona Willer is an Advanced Accredited Practising Dietitian and Fellow of the Higher Education Academy renowned for her advocacy of weight-neutral practices in healthcare. Throughout the podcast episode, Fiona shares insights on why a weight neutral approach is necessary to progress population wellbeing, and how community health and food practi…
  continue reading
 
Will glucagon with GLP-1 be a new combination weight management treatment? How could these 2 hormones work together to facilitate weight loss? Learn more: https://drsue.ca/2024/02/will-glucagon-with-glp1-be-a-new-combination-weight-management-treatment/ Any medical discussion on this podcast is intended to be of a general nature only, and is intend…
  continue reading
 
There are many important strategies to protect the kidneys of people with type 2 diabetes. Could a longer time at a target weight loss be one of them? Learn more: https://drsue.ca/2024/02/could-spending-more-time-at-a-target-weight-protect-against-kidney-failure-in-people-with-type-2-diabetes/ Any medical discussion on this podcast is intended to b…
  continue reading
 
Rare post marketing case reports of suicidality have emerged amongst people taking GLP1 receptor agonists for diabetes or obesity. What new data do we have on this, and where are global regulatory agencies at in their investigations? Learn more: https://drsue.ca/2024/01/update-are-glp1-receptor-agonist-medications-for-weight-management-and-diabetes…
  continue reading
 
What are the risks associated with the RSV virus, and should you be vaccinated? Learn more: https://drsue.ca/2024/01/should-you-get-the-rsv-vaccine/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor…
  continue reading
 
Why do so many people stop weight management medication - and why does it matter? Learn more: https://drsue.ca/2024/01/why-do-so-many-people-stop-their-weight-management-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specifi…
  continue reading
 
We know that elevated weight is a key risk factor for developing type 2 diabetes. Does carrying elevated weight increase the risk of developing autoimmune type 1 diabetes as well? Learn more: https://drsue.ca/2024/01/does-obesity-increase-the-risk-of-developing-autoimmune-type-1-diabetes/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
Miss any key advancements and challenges in the field of weight management in 2023? Join me for the highlights here! Learn more: https://drsue.ca/2023/12/dr-sues-weight-management-highlights-2023/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed …
  continue reading
 
Could Alexa AI help people titrate insulin (for diabetes) or GLP1 receptor agonists (for diabetes or weight management)? Learn more: https://drsue.ca/2023/12/could-ai-help-to-optimize-insulin-or-glp1-receptor-agonist-therapy/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. …
  continue reading
 
Weight management medications are expensive, and often on shortage. What happens if we treat intermittently (on and off)? Learn more: https://drsue.ca/2023/12/should-we-consider-on-off-intermittent-treatment-with-weight-loss-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian…
  continue reading
 
Just how does obesity increase the risk of so many types of cancer? Learn more: https://drsue.ca/2023/12/how-does-obesity-increase-cancer-risk/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to t…
  continue reading
 
Semaglutide 2.4mg (Wegovy) is the first weight management medication ever to show that it reduces cardiovascular events. Read more about this here! Learn more: https://drsue.ca/2023/11/semaglutide-wegovy-first-weight-management-medication-in-the-world-to-show-reduction-in-cardiovascular-events/ Any medical discussion on this podcast is intended to …
  continue reading
 
Tirzepatide (Mounjaro) is very effective for improvement in blood sugar control and weight loss. Find out about this exciting new addition to Canada's treatment options for type 2 diabetes. Learn more: https://drsue.ca/2023/10/tirzepatide-now-available-in-canada-how-to-with-vial-and-syringe/ Any medical discussion on this podcast is intended to be …
  continue reading
 
What are cravings exactly? And what tools do we have available to combat them? Learn more: https://drsue.ca/2023/09/what-are-cravings-and-how-can-we-reduce-them/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to …
  continue reading
 
Does every pound of muscle that replaces fat really burn an extra 50 calories per day? Is slow, gradual weight loss really better than losing a large amount quickly? Find out the answers to these questions and more! Learn more: https://drsue.ca/2023/10/30-myths-about-obesity-part-2/ Any medical discussion on this podcast is intended to be of a gene…
  continue reading
 
Is fat under the skin (subcutaneous) really healthy? Does cutting back food intake by 500 calories per day really result in 1 pound of weight loss per week? Find out the answers to these questions and more! Learn more: https://drsue.ca/2023/09/30-myths-about-obesity-part-1/ Any medical discussion on this podcast is intended to be of a general natur…
  continue reading
 
What's new with the Freestyle Libre (2 and 3), the Dexcom (G7), and the Medtronic (Guardian 4) in Canada? Learn more: https://drsue.ca/2023/10/advances-in-blood-sugar-monitoring-technology-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not design…
  continue reading
 
With new and emerging evidence for the benefits of weight management medication far beyond simply weight loss, should we reframe and fine tune our targets further? Learn more: https://drsue.ca/2023/11/weight-management-what-does-it-mean-to-treat-to-target-with-medication/ Any medical discussion on this podcast is intended to be of a general nature …
  continue reading
 
Many women with polycystic ovary syndrome struggle with elevated weight. What do the new guidelines say about weight management? Learn more: https://drsue.ca/2023/11/polycystic-ovary-syndrome-pcos-what-do-the-new-guidelines-say-about-weight-management/ Any medical discussion on this podcast is intended to be of a general nature only, and is intende…
  continue reading
 
Loading …

Skrócona instrukcja obsługi